Sickle cell CRISPR 'cure' is the start of a revolution in medicine
The approval of a CRISPR treatment, for sickle cell and beta thalassemia, is just the start for a technology still in its infancy
The approval of a CRISPR treatment, for sickle cell and beta thalassemia, is just the start for a technology still in its infancy
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
